Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEACHCOVID: Hydroxychloroquine and Azithromycin in COVID-19
NCT04347512Phase 3Withdrawn
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19), sponsored by Strasbourg University Hospital. Planned start Jun 2020; status: withdrawn.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04347512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04347512.